Quantifying the Unknowns of Plaque Morphology: The Role of Topological Uncertainty in Coronary Artery Disease

This article aimed to explore topological uncertainty in medical imaging, particularly in assessing coronary artery calcification using artificial intelligence (AI). Topological uncertainty refers to ambiguities in spatial and structural characteristics of medical features, which can impact the interpretation of coronary plaques. The article discusses the challenges of integrating AI with topological considerations and the need for specialized methodologies beyond traditional performance metrics. It highlights advancements in quantifying topological uncertainty, including the use of persistent homology and topological data analysis techniques. The importance of standardization in methodologies and ethical considerations in AI deployment are emphasized. It also outlines various types of uncertainty in topological frameworks for coronary plaques, categorizing them as quantifiable and controllable or quantifiable and not controllable. Future directions include developing AI algorithms that incorporate topological insights, establishing standardized protocols, and exploring ethical implications to revolutionize cardiovascular care through personalized treatment plans guided by sophisticated topological analysis. Recognizing and quantifying topological uncertainty in medical imaging as AI emerges is critical. Exploring topological uncertainty in coronary artery disease will revolutionize cardiovascular care, promising enhanced precision and personalization in diagnostics and treatment for millions affected by cardiovascular diseases.

Authors

Institutions

Publication Details

Journal
Mayo Clinic Proceedings Digital Health
Published
2025-04-01
DOI
https://doi.org/10.1016/j.mcpdig.2025.100217
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantifying the Unknowns of Plaque Morphology: The Role of Topological Uncertainty in Coronary Artery Disease

Bradley J. Erickson, Deepak L. Bhatt, Leslee J. Shaw, Francisco Lopez‐Jimenez et al.
Mayo Clinic Proceedings Digital Health
Cerebrovascular and Carotid Artery Diseases
article

Quantifying the Unknowns of Plaque Morphology: The Role of Topological Uncertainty in Coronary Artery Disease

Bradley J. Erickson, Deepak L. Bhatt, Leslee J. Shaw, Francisco Lopez‐Jimenez, Quincy A. Hathaway, Karthik Dinakar, Yashbir Singh
article en

Abstract

This article aimed to explore topological uncertainty in medical imaging, particularly in assessing coronary artery calcification using artificial intelligence (AI). Topological uncertainty refers to ambiguities in spatial and structural characteristics of medical features, which can impact the interpretation of coronary plaques. The article discusses the challenges of integrating AI with topological considerations and the need for specialized methodologies beyond traditional performance metrics. It highlights advancements in quantifying topological uncertainty, including the use of persistent homology and topological data analysis techniques. The importance of standardization in methodologies and ethical considerations in AI deployment are emphasized. It also outlines various types of uncertainty in topological frameworks for coronary plaques, categorizing them as quantifiable and controllable or quantifiable and not controllable. Future directions include developing AI algorithms that incorporate topological insights, establishing standardized protocols, and exploring ethical implications to revolutionize cardiovascular care through personalized treatment plans guided by sophisticated topological analysis. Recognizing and quantifying topological uncertainty in medical imaging as AI emerges is critical. Exploring topological uncertainty in coronary artery disease will revolutionize cardiovascular care, promising enhanced precision and personalization in diagnostics and treatment for millions affected by cardiovascular diseases.

Mayo Clinic Proceedings Digital HealthVol. 3(2)
Fujita Health University (JP), Mount Sinai Hospital (US), Mayo Clinic in Arizona (US), Massachusetts Institute of Technology (US), University of Pennsylvania (US), Chiba Institute of Technology (JP), Icahn School of Medicine at Mount Sinai (US)
American Heart Association, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Brigham and Women's Hospital, Alnylam Pharmaceuticals, Cleveland Clinic, CSL Behring, Boston Scientific Corporation, Regeneron Pharmaceuticals, Ironwood Pharmaceuticals, Incorporated, Amarin Corporation, Medicines Company, MyoKardia, Belvoir Media Group, Moderna, Novo Nordisk, Assistance publique-Hôpitaux de Paris, Idorsia Pharmaceuticals, HLS Therapeutics, National Institutes of Health, St. Jude Medical, Duke Clinical Research Institute, Daiichi Sankyo Europe
Openalex Percentile: Top 90%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.